Slingshot members are tracking this event:
Merck’s BRIDION (sugammadex) Receives FDA Approval for the Reversal of Neuromuscular Blockade Induced by Rocuronium and Vecuronium in Adults Undergoing Surgery
Slingshot Insights Explained
Dec 17, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Bridion, Sugammadex, Fda, Approval